Ultrasonographic Measurements of the Median Nerve Before and After Splinting for Carpal Tunnel Syndrome
Completed
- Conditions
- Carpal Tunnel Syndrome
- Registration Number
- NCT02038205
- Lead Sponsor
- University of California, Davis
- Brief Summary
A prospective cohort follow-up study design is undertaken. Both males and females with mild to moderate carpal tunnel syndrome will receive standard-of-care wrist splint for 6 weeks and undergo follow up studies for data collection. Controls will also be seen for a one time visit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 213
Inclusion Criteria
- 18 years or older and;
- Diagnosis of mild to moderate CTS with median motor latency at 8 cm is greater than 4.5 milliseconds or Combined Sensory Index > 0.9 where first line therapy is indicated to include nocturnal wrist bracing
- Control subjects without symptoms of carpal tunnel syndrome.
Exclusion Criteria
- Evidence of severe CTS as seen with electromyographic changes in the body of the muscle
- Untreated hypothyroidism, Rheumatologic disorders
- Diagnosed Severe CTS or Chronic symptoms of carpal tunnel, greater than 1 year, this includes wasting of the hand muscles
- Undergoing or previously treated for carpal tunnel on affected side. This includes surgery (carpal tunnel release), corticosteroid injections, bracing within the last 3 months while wearing the brace consistently every night, or any other intervention.
- Currently pregnant or < 3 months post partum
- History of wrist, hand fracture or severe trauma to affected hand and/or wrist
- Known tumor, mass or deformity of the hand/wrist
- Inflammatory articular disease of the joints or tendons Existing cervical radiculopathy or previous surgeries to the neck for radicular symptoms
- History of electrodiagnostic evidence of generalized polyneuropathy or evidence of denervation
- Diagnosed neuromuscular disorders which may complicate CTS diagnosis
- Implanted electronic device (pacemaker, intrathecal pump/stimulator)
- Any illness that makes it unsafe for the patient to participate in the study
- Not fluent in English as NeuroQOL and other subjective information is limited to the English language interpretation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cross sectional area of median nerve using ultrasound 6 weeks
- Secondary Outcome Measures
Name Time Method Patient-reported outcome measures using NeuroQOL and CTSAQ 6 weeks Motor latency, motor amplitude, sensory velocity and sensory amplitude with electrodiagnostic study 6 weeks cross sectional area, electrodiagnostic study, age, gender, height, weight, BMI, wrist circumference, wrist width. smoking and handedness as predictors of improvement (or no improvement) in the NeuroQOL and CTSAQ-measured clinical severity scale. 6 weeks
Trial Locations
- Locations (1)
UC Davis Medical Center
🇺🇸Sacramento, California, United States